A carregar...

Chemokines as Cancer Vaccine Adjuvants

We are witnessing a new era of immune-mediated cancer therapies and vaccine development. As the field of cancer vaccines advances into clinical trials, overcoming low immunogenicity is a limiting step in achieving full success of this therapeutic approach. Recent discoveries in the many biological r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bobanga, Iuliana D., Petrosiute, Agne, Huang, Alex Y.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067044/
https://ncbi.nlm.nih.gov/pubmed/24967094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines1040444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!